| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL MYERS SQUIBB CO | $92.81B | $45.59 | $40.50 | -11.16% | Sell | 2 | -3.55% | 25.52% | 61.36% | 11.75% | |||
| LLY | ELI LILLY & CO | $857.33B | $906.86 | $916.38 | 1.05% | Strong Buy | 8 | 13.44% | 22.53% | 174.93% | 36.21% | |||
| GSK | GSK PLC | $94.44B | $46.82 | N/A | N/A | N/A | N/A | -5.16% | -17.69% | 42.83% | 11.27% | |||
| AMRN | AMARIN CORP PLC | $316.05M | $15.20 | $12.00 | -21.05% | Strong Sell | 1 | -4.16% | N/A | 50.84% | 35.36% | |||
| GRFS | GRIFOLS SA | $6.34B | $9.22 | $10.30 | 11.71% | Hold | 1 | 2.33% | 69.33% | 16.33% | 4.49% | |||
| ABBV | ABBVIE INC | $381.56B | $215.89 | $249.92 | 15.76% | Strong Buy | 12 | 6.88% | 131.71% | -1,193.79% | 23.56% | |||
| GILD | GILEAD SCIENCES INC | $152.62B | $123.00 | $130.20 | 5.85% | Strong Buy | 10 | 3.64% | 23.25% | 64.56% | 22.79% | |||
| AZN | ASTRAZENECA PLC | $254.29B | $82.03 | N/A | N/A | N/A | N/A | 5.94% | 64.13% | 45.94% | 18.28% | |||
| JNJ | JOHNSON & JOHNSON | $450.20B | $186.86 | $196.60 | 5.21% | Buy | 15 | 4.31% | 6.04% | 40.02% | 16.45% | |||
| SNY | SANOFI | $124.06B | $49.11 | $58.00 | 18.10% | Strong Buy | 1 | 0.36% | 28.31% | 15.32% | 8.58% | |||
| NVS | NOVARTIS AG | $240.77B | $125.01 | $118.00 | -5.61% | Strong Sell | 1 | 2.14% | 11.37% | 50.34% | 20.80% | |||
| SCLX | SCILEX HOLDING CO | $137.17M | $19.72 | N/A | N/A | N/A | N/A | 127.94% | N/A | -27.10% | 80.56% | |||
| PFE | PFIZER INC | $138.16B | $24.30 | $29.33 | 20.71% | Hold | 3 | -0.54% | 22.60% | 16.95% | 7.54% | |||
| AMGN | AMGEN INC | $159.73B | $296.70 | $305.88 | 3.09% | Hold | 8 | 2.85% | 22.77% | 169.38% | 14.31% | |||
| MRK | MERCK & CO INC | $209.46B | $83.86 | $93.75 | 11.79% | Hold | 4 | 4.45% | 17.07% | 56.82% | 23.69% | |||
| BIIB | BIOGEN INC | $21.91B | $149.33 | $161.80 | 8.35% | Buy | 10 | -2.44% | 13.75% | 13.51% | 8.42% | |||
| OGN | ORGANON & CO | $1.69B | $6.52 | $14.00 | 114.72% | Buy | 2 | 0.90% | 16.00% | 160.12% | 8.69% | |||
| MIRA | MIRA PHARMACEUTICALS INC | $29.94M | $1.57 | N/A | N/A | N/A | N/A | N/A | N/A | -324.26% | -212.80% | |||
| MDCX | MEDICUS PHARMA LTD | $39.20M | $2.20 | $23.50 | 968.18% | Strong Buy | 2 | N/A | N/A | -83.91% | -22.84% | |||
| NSRX | NASUS PHARMA LTD | N/A | $8.00 | $22.00 | 175.00% | Strong Buy | 1 | N/A | N/A | N/A | N/A |